Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function

Hypertension

Volumn 54, Issue 3, 2009, Pages 612-618

  Palmer, Suetonia C ^a   Prickett, Timothy C R ^a   Espiner, Eric A ^a   Yandle, Timothy G ^a   Richards, A Mark ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Circulation; Glomerular filtration rate; Human; Natriuretic peptides; Plasma

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC PEPTIDE TYPE C; TROPONIN I; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76); PROTEIN PRECURSOR;

ADULT; AGE DISTRIBUTION; ARTERY; ARTICLE; CARDIOVASCULAR DISEASE; CIRCULATION; CONTROLLED STUDY; FEMALE; HEAD; HEART; HEART CATHETERIZATION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; KIDNEY PARENCHYMA; LIVER; LUNG ARTERY PRESSURE; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL SYSTEM; NECK; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN SECRETION; SCORING SYSTEM; TISSUE SPECIFICITY; VEIN; AGED; BLOOD; CHEMISTRY; ECHOCARDIOGRAPHY; HEMODYNAMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; RADIOIMMUNOASSAY;

AGED; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDE, C-TYPE; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; RADIOIMMUNOASSAY;

EID: 70349257488     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.135608     Document Type: Article

References (41)

1. Horio T, Tokudome T, Maki T, Yoshihara F, Suga S, Nishikimi T, Kojima M, Kawano Y, Kangawa K. Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts. Endocrinology. 2003;144:2279-2284.
2. Clavell A, Stingo A, Wei C, Heublein D, Burnett JC Jr. C-type natriuretic peptide: a selective cardiovascular peptide. Am J Physiol. 1993;264: R290-R295. (Pubitemid 23085888)
3. Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev. 2006;27:47-72.
4. Sudoh T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun. 1990;168:863-870. (Pubitemid 20164622)
5. Stingo A, Clavell A, Heublein D, Wei C, Pittelkow M, Burnett J. Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol. 1992;263:H1318-H1321.
6. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta: possible existence of "vascular natriuretic peptide system." J Clin Invest. 1992;90:1145-1149.
7. Vollmar A, Gerbes A, Nemer M, Schulz R. Detection of C-type natriuretic peptide transcript in the rat heart and immune organs. Endocrinology. 1993; 132:1872-1874.
8. Wei CM, Heublein DM, Perrella MA, Lerman A, Rodeheffer RJ, McGregor CG, Edwards WD, Schaff HV, Burnett JC Jr. Natriuretic peptide system in human heart failure. Circulation. 1993;88:1004-1009.
9. Mattingly MT, Brandt RR, Heublein DM, Wei CM, Nir A, Burnett JC Jr. Presence of C-type natriuretic peptide in human kidney and urine. Kidney Int. 1994;46:744-747.
10. Hagiwara H, Sakaguchi H, Itakura M, Yoshimoto T, Furuya M, Tanaka S, Hirose S. Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B. J Biol Chem. 1994;269:10729-10733.
11. Nielsen S, Goetze J, Jensen H, Rehfeld J. ProCNP and CNP are expressed primarily in male genital organs. Regul Pept. 2008;146:204-212.
12. Walther T, Stepan H. C-type natriuretic peptide in reproduction, pregnancy and fetal development. J Endocrinol. 2004;180:17-22.
13. Koller K, Lowe D, Bennet G, Minamino N, Kangawa K, Matsuo H, Goeddel D. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science. 1991;252:120-123.
14. Langub MC Jr, Dolgas C, Watson RE Jr, Herman J. The C-type natriuretic peptide receptor is the predominant natriuretic peptide receptor mRNA expressed in rat hypothalamus. J Neuroendocrinol. 1995;7: 305-309.
15. Hutchinson H, Trinlade P, Cunanan D, Wu C, Pratt R. Mechanisms of natriuretic-peptide-growth inhibition of vascular smooth muscle cells. Cardiovasc Res. 1997;35:158-167.
16. Doyle DD, Upshaw-Earley J, Bell E, Palfrey H. Natriuretic peptide receptor-B in adult rat ventricle is predominantly confined to the nonmyocyte population. Am J Physiol. 2002;282:H2117-H2123.
17. Tolsa J-F, Gao Y, Sander F, Souici A-C, Usha Raj J. Differential responses of newborn pulmonary arteries and veins to atrial and C-type natriuretic peptides. Am J Physiol Heart Circ Physiol. 2002;282: H273-H280.
18. Beaulieu P, Cardinal R, Page P, Francoeur F, Tremblay J, Lambert C. Positive chronotropic and inotropic effects of C-type natriuretic peptide in dogs. Am J Physiol Heart Circ Physiol. 1997;273:H1933-H1940.
19. Soeki T, Kishimoto I, Okumura H, Tokudome T, Horio T, Mori K, Kangawa K. C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction. J Am Coll Cardiol. 2005;45:608-616.
20. Wright S, Prickett T, Doughty R, Frampton C, Sharpe N, Richards M. Amino-terminal pro-C-type natriuretic peptide in heart failure. Hypertension. 2004;43:94-100.
21. Del Ry S, Maltinti M, Cabiati M, Emdin M, Giannessi D, Morales M. C-type natriuretic peptide and its relation to non-invasive indices of left ventricular function in patients with chronic heart failure. Peptides. 2008; 29:79-82.
22. Kalra PR, Clague JR, Bolger AP, Anker SD, Poole-Wilson PA, Struthers AD, Coats AJ. Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation. 2003;107:571-573.
23. Nielsen S, Rehfeld J, Pedersen F, Kastrup J, Videback R, Goetze J. Measurement of pro-C-type natriuretic peptide in plasma. Clin Chem. 2005;51:2173-2176.
24. Del Ry S, Maltini M, Piacenti M, Passino C, Emdin M, Giannessi D. Cardiac production of C-type natriuretic peptide in heart failure. J Cardiovasc Med. 2006;7:397-399.
25. Kuo JY, Yeh HI, Chang SH, Shih BF, Wang AM, Chen CY, Hou CJY. C-type natriuretic peptide in individuals with normal left ventricular systolic function. Scand Cardiovasc J. 2007;41:155-159.
26. Gülberg V, Møller S, Henriksen JH, Gerbes AL. Increased renal production of C-type natriuretic peptide (CNP) in patients with cirrhosis and functional renal failure. Gut. 2000;47:852-857.
27. Matsukawa N, Grzesik W, Takahashi N, Pandey K, Pang S, Yamauchi M, Smithies O. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci U S A. 1999;96:7403-7408.
28. Brandt R, Heublein D, Aarhus L, Lewicki J, Burnett JC Jr. Role of natriuretic peptide clearance receptor in in vivo control of C-type natriuretic peptide. Am J Physiol Heart Circ Physiol. 1995;269:H326-H331.
29. Prickett TC, Yandle TG, Nicholls MG, Espiner EA, Richards AM. Identification of amino-terminal pro-C-type natriuretic peptide in human plasma. Biochem Biophys Res Commun. 2001;286:513-517.
30. Wu C, Wu F, Pan J, Morser J, Wu Q. Furin-mediated processing of Pro-C-type natriuretic peptide. J Biol Chem. 2003;278:25847-25852.
31. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; for the Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461-470.
32. Brandt PWT, Partridge JB, Wattie WJ. Coronary arteriography: method of presentation of the arteriogram and a scoring system. Clin Radiol. 1977;28:361-365.
33. Schiller NB, Shah P, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I; for the American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358-367.
34. Prickett T, Kaaja R, Nicholls MG, Espiner EA, Richards AM, Yandle TG. N-terminal pro-C-type natriuretic peptide, but not C-type natriuretic peptide, is greatly elevated in the fetal circulation. Clin Sci (Lond). 2004;106:535-540.
35. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactive amino-terminal pro-brain natriuretic peptide (NTPROBNP): a new marker of cardiac impairment. Clin Endocrinol. 1997; 47:287-296.
36. Yandle TG, Fisher S, Charles C, Espiner E, Richards A. The ovine hypothalamus and pituitary have markedly different distributions of C-type natriuretic peptide forms. Peptides. 1993;14:713-716.
37. Yandle TG, Richards AM, Gilbert A, Fisher S, Holmes S, Espiner EA. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab. 1993;76:832-838.
38. Nielsen SJ, Rehfeld JF, Goetze JP. Mismeasure of C-type natriuretic peptide [letter]. Clin Chem. 2008;54:225-227.
39. Brown L, Nunez D, Wilkins M. Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat. J Clin Invest. 1993;92:2702-2712.
40. Kerr MA, Kenny AJ. The molecular weight and properties of a neutral metallo-endopeptidase from rabbit kidney brush border. Biochem J. 1974; 137:489-495.
41. Charles CJ, Prickett TC, Espiner EA, Rademaker MT, Richards AM, Yandle TG. Regional sampling and the effects of experimental heart failure in sheep: differential responses in A, B and C-type natriuretic peptides. Peptides. 2006;27:62-68.